Danish pharmaceutical giant Novo Nordisk has launched its widely known drug Ozempic (semaglutide injection) in India. The medication is primarily prescribed for the treatment of Type-2 diabetes, but it has gained global attention for its significant weight-loss benefits.Ozempic is now available in India in 0.25 mg, 0.50 mg, and 1